TAGS: in-cosmetics Skin Care
Clariant has unveiled new seaweed active ingredient Epseama™ pioneers at in-cosmetics Global 2019, the targeting of long non-coding RNA nc886 to improve signs of rejuvenate skin, reinvigorate its self-defense abilities and preserve skin youth.
Slowing Down Aging Process
Consumers’ fascination with slowing down the aging process shows little sign of waning. Indeed, the global
anti-aging products market size will grow by USD 17.2 billion during 2019-2023, with the increasing older population between the ages of 30-45 and motivation to look younger among the key drivers for this expansion.
Commonly known causes of aging are the genetically-determined factors (chronoaging), extrinsic factors like UV exposure (photoaging), and chronic inflammation. They are also at play in causing the decay of skin structure.
Epseama™ takes an innovative and differentiated approach and goes down to the root cause triggered by these three factors. It does so by targeting the long non-coding RNA, called “nc886”, recently recognized as a key regulator of PKR, a protein known for inducing premature aging in various diseases and organs. Subsequent ground-breaking research by Clariant Active Ingredients into the unexplored impact of nc886 in the skin, demonstrated the correlation between aging and the decrease of nc886 expression. The result: when properly expressed nc886 is a fundamental player in the rejuvenation of skin. With Epseama™, the industry can develop effective skincare directed at the true causes of aging.
Targeting the 3 Players in Aging
Derived from a “superfood of the sea”, Epseama™ draws on the extensive nutrient power of a brown seaweed Laminaria japonica (Kelp or Kombu) for its effectiveness. It is farmed off the coast of a South Korean island and involves “ugly-food” sourcing.
Epseama™ through in vitro, ex vivo and clinical tests has proven to be the best candidate for skin rejuvenation as it targets chronoaging, photoaging and inflammaging at once – the three important players in aging and the cause of drastic alterations to skin structure, pigmented spots and impairment of the epidermis thickness, for example.
It gets to the heart of these problems by addressing the real cause of aging and reverting its natural course. It does so by increasing nc886 production in order to prevent damage to the dermal-epidermal junction. As a result, wrinkles, skin roughness and skin dehydration all show signs of improvement. It prevents collagen IV degradation through direct inhibition of MMP-9, and boosts it so that the junction between the epidermis and dermis is strengthened. Epseama™ heightens keratinocytes proliferation by improving the synthesis of CD44 hyaluronic acid receptors. It also enhances epidermis thickness, and inhibits the inflammasome pathway.
Its outstanding performance is confirmed in clinical trials on 19 women over 50 after only four weeks. In terms of wrinkle reduction, Epseama™ achieves outstanding consumer benefits. Difficult to remove nasolabial wrinkles are smoothed - reduced by 19% in volume and 10% in roughness after only four weeks. Spots decreased by 10% and skin moisture levels increased by 14.2%.
New Approach to Skin Health & Well-being
Julie Droux, Senior Technical Marketing Specialist, Clariant Active Ingredients, commented: “By 2050, the over-60s are projected to make up over 21% of the global population[2]. This, together with the increasing middle-aged population, presents a big opportunity for Personal Care to contribute new approaches to aging and wellness. Understanding the biological processes that influence skin aging processes makes us better placed to focus our innovation on advanced ingredients to delay it. Ideally supported by a natural focus and good traceability that fit with consumer preferences. By uniquely targeting nc886, Epseama™ offers formulators a new source of rejuvenation erasing age-related and photo-related signs, tackling the true causes of skin aging with an ingredient derived from the sea.”
Source: Clariant